Here is the detailed overview of Buprenorphine (A) + Naloxone (B) Sublingual Tablet 2 mg + 0.5 mg, with icons:
๐ Buprenorphine + Naloxone Sublingual Tablet
Strength: 2 mg (Buprenorphine) + 0.5 mg (Naloxone)
Route: ๐
Sublingual (placed under the tongue)
๐งช Nature / Drug Class
๐น Buprenorphine โ Partial ฮผ-opioid receptor agonist
๐น Naloxone โ Opioid antagonist
๐น Combined to treat opioid use disorder (OUD)
๐น Designed to discourage abuse via injection
๐ฉบ Purpose / Indications
โ Used in:
- ๐ Opioid dependence / maintenance therapy
- ๐ฌ Opioid detoxification programs
- ๐ฅ Medication-assisted therapy in de-addiction centers
- Often a step-up dose after 0.4/0.1 mg or 1/0.25 mg initiation
โ๏ธ Advantages
โ๏ธ Reduces withdrawal symptoms and cravings
โ๏ธ Long-acting โ may be used once or twice daily
โ๏ธ Naloxone component deters parenteral abuse
โ๏ธ Lower overdose risk compared to full agonists like methadone
โ๏ธ Can be prescribed for outpatient management (with monitoring)
๐ฆ Common Packaging
๐ฆ Tablets in blister strips or unit-dose packs
๐ Often used in combination with higher strength tablets (e.g., 8 mg/2 mg)
๐ Regulated under Narcotic Drugs and Psychotropic Substances (NDPS) Act in India
โ ๏ธ Patient Advice / Precautions
๐
Place under the tongue until dissolved โ do not chew/swallow
โฐ Maintain regular timing and dosage
๐ซ Avoid alcohol, sedatives, or benzodiazepines โ risk of sedation
๐งพ Requires medical supervision and follow-up
๐ง Rinse mouth after use for oral hygiene
๐ Do not discontinue suddenly โ taper as advised
๐ซ Contraindications / Cautions
โ Allergy to buprenorphine or naloxone
โ Severe respiratory depression or liver disease
โ ๏ธ Use with caution in:
- Pregnancy (specialist protocol advised)
- Concurrent CNS depressants
- Severe psychiatric illness
๐ง Storage
๐ก๏ธ Store at 15โ30ยฐC
๐ Keep in a secure, locked place to prevent misuse
๐ง Keep out of reach of children